Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection.
Gutierrez-Aranda
Ivan
I
Ramos-Mejia
Veronica
V
Bueno
Clara
C
Munoz-Lopez
Martin
M
Real
Pedro J
PJ
Mácia
Angela
A
Sanchez
Laura
L
Ligero
Gertrudis
G
Garcia-Parez
Jose L
JL
Menendez
Pablo
P
D000782:Aneuploidy; D000818:Animals; D002460:Cell Line; D053595:Embryonic Stem Cells / Q000637:transplantation*; D018507:Gene Expression Regulation, Developmental; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D057026:Induced Pluripotent Stem Cells / Q000637:transplantation*; D007267:Injections; D007279:Injections, Subcutaneous; D053631:Interleukin Receptor Common gamma Subunit / Q000172:deficiency / Q000235:genetics; D008297:Male; D051379:Mice; D016688:Mice, Inbred NOD; D018345:Mice, Knockout; D016513:Mice, SCID; D013724:Teratoma / Q000235:genetics / Q000473:pathology*; D013737:Testis; D013997:Time Factors
C507942:Il2rg protein, mouse; D053631:Interleukin Receptor Common gamma Subunit